Aviva sells Singlife joint venture stake for $1.2 billion
Reuters
Published Mar 18, 2024 07:14
Updated Mar 18, 2024 07:25
By Elizabeth Howcroft
LONDON (Reuters) -Aviva has completed the sale of its stake in Singapore Life Holdings, plus two debt instruments, for a combined 937 million pounds ($1.19 billion), the British insurer said in a statement on Monday.
Aviva (LON:AV) announced in September that its 25.9% stake and the two debt instruments would be sold to Sumitomo Life. The sale was expected to be completed in the fourth quarter of last year.
Aviva Chief Executive Amanda Blanc said in September that the transaction would simplify the business and put the company in a strong position to build on its trading momentum in the UK, Ireland and Canada.
The Singlife joint venture contributed 17 million pounds to Aviva's operating profit in 2022, Aviva has said.
Aviva announced a 300 million pound share buyback earlier this month, after strong performance in general and health insurance contributed to a 9% rise in 2023 operating profit, sending its shares higher.
($1 = 0.7853 pounds)
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.